25 results on '"Ghesquiere, Bart"'
Search Results
2. MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy
3. Glycosphingolipids in congenital disorders of glycosylation (CDG)
4. Neural and metabolic dysregulation in PMM2-deficient human in vitro neural models
5. Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy
6. Tracer metabolomics reveals the role of aldose reductase in glycosylation
7. Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction
8. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming
9. Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells
10. Differential roles for the oxygen sensing enzymes PHD1 and PHD3 in the regulation of neutrophil metabolism and function
11. Ancient genomic linkage couples metabolism with erythroid development
12. HIF-1α-mediated mitochondrial-glycolytic reprogramming controls the transition of precursor to terminally exhausted T cells
13. NRF2 Activation Reprograms Defects in Oxidative Metabolism to Restore Macrophage Function in Chronic Obstructive Pulmonary Disease
14. NRF2 activation reprogrammes defects in oxidative metabolism to restore macrophage function in COPD
15. The sodium‐glucose co‐transporter‐2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis
16. Author response for 'The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis'
17. RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
18. RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
19. RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
20. Antizyme Inhibitor 1 regulates matrikine expression and enhances the metastatic potential of aggressive primary prostate cancer
21. ANTIMETABOLIC COOPERATIVITY WITH THE CLINICALLY-APPROVED L-ASPARAGINASE AND TYROSINE KINASE INHIBITORS TO ERADICATE CML STEM CELLS
22. SAT-390 - Distinct immunometabolic signatures in circulating immune cells define disease outcomes in acute-on-chronic liver failure
23. Differential roles for the oxygen sensing enzymes PHD1 and PHD3 in the regulation of neutrophil metabolism and function.
24. Biallelic variants in COX18 cause a mitochondrial disorder primarily manifesting as peripheral neuropathy.
25. Ancient genomic linkage couples metabolism with erythroid development.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.